首页> 外文期刊>Circulation. Heart failure >Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)
【24h】

Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)

机译:临床试验部位登记对患者特征,方案完成和终点的影响:ASCEND-HF试验的启示(奈西立肽治疗失代偿性心力衰竭的临床有效性的急性研究)

获取原文
获取原文并翻译 | 示例
           

摘要

Background Most international acute heart failure trials have failed to show benefit with respect to key end points. The impact of site enrollment and protocol execution on trial performance is unclear.
机译:背景技术大多数国际急性心力衰竭试验未能在关键终点方面显示出益处。尚不清楚站点注册和协议执行对试验性能的影响。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号